Skip to content

The Effect of Heat-Treated Fermented Milk on Functional Constipation population

The Effect of Heat-Treated Fermented Milk on Functional Constipation population

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111771
Enrollment
Unknown
Registered
2025-11-05
Start date
2025-11-10
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional constipation

Interventions

Placebo group:placebo
Test group:Heat-treated fermented milk (postbiotics)

Sponsors

China Agricultural University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age:45-75 years old; 2.BMI:18.5-34.9 kg/m2; 3. Meets the Rome IV diagnostic criteria for constipation; Must include 2 or more of the following: a. More than 1/4 (25%) of bowel movements are dry balls or hard stools (Bristol Fecal Characteristics Scale 1-2) b. More than 1/4 (25%) of cases have incomplete bowel movements c. More than 1/4 (25%) of bowel movements have anorectal obstruction/blockage sensation d. More than 1/4 (25%) of bowel movements require manual assistance (such as finger assisted defecation, pelvic floor support) e. Spontaneous bowel movements (SBM) less than 3 times per week When not using laxatives, there is rarely loose stool The symptoms before diagnosis have been present for at least 6 months and have met the above diagnostic criteria in the past 3 months. 4. Voluntarily participate in this experiment and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Have serious gastrointestinal diseases (gastric or duodenal ulcers, acute enteritis, ulcerative colitis) or significant organic lesions (colon cancer, tumors, etc.); 2. Suffering from type 1 diabetes, Parkinson's disease or any disease requiring chronic treatment; 3. Two weeks prior to the experiment, use H2 receptor antagonists, proton pump inhibitors (CPPI), or consume probiotic or prebiotic preparations; 4. Use any of the following medications three days before randomization:; a. Prokinetic agents (Tegaserod, Domperidone, Cisapride, Metoclopramide, Erythromycin) b. Containing opiate drugs c. Antispasmodic agents (atropine, hyoscyamine, scopolamine, glycopyrrolate) d. Chronic nonsteroidal anti-inflammatory drugs (NSAIDs) e. Antibiotics and laxatives; 5. Excessive smoking and drinking; 6. Women who are pregnant, breastfeeding, or planning to become pregnant within the next 6 months; 7. Allergic to milk and soybeans.

Design outcomes

Primary

MeasureTime frame
Whole gut transit time;Number of spontaneous bowel movement;Number of complete spontaneous bowel movement;

Secondary

MeasureTime frame
Patient Assessment of Constipation symptom;Patient Assessment of Constipation Quality Of Life;Chronic Constipation Severity Rating Scale;Bristol Stool Form Scale;Perceived Stress Scale;Depression Anxiety Stress Scale;Pittsburgh Sleep Quality Index;Neurotransmitter;Inflammatory cytokines;Gut microbiota;Gut microbial metabolites;

Countries

China

Contacts

Public ContactJingjing He

China Agricultural University

hejingjing89@cau.edu.cn+86 151 2009 2404

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 30, 2026